to interact synergistically with IL-7 and to stimulate proliferation of B-lineage cells?6 In addition to these proliferative stimuli, stromal cells secrete an activity(s) that allows B220-precursors to mature to Ig expression. Stromal cell line S17 was previously shown to secrete cytokines that potentiated this differentiative step, and that process appeared to involve little or no proliferation."
(IL-7) in potentiating pre-B-cell proliferation, few studies have addressed the possibility that multiple cytokines are involved in the progression of early events in cellular differentiation and proliferation in this hematopoietic lineage. Our laboratory previously described pre-B-cell differentiation mediated by the bone marrow stromal cell line S17. In this study, we further delineate the role of stromal cells in differentiation and proliferation of pre-B cells. These experi-TUDIES OF THE regulation of B-lymphocyte differen-S tiation have only recently become feasible, owing primarily to the development of lymphoid long-term bone marrow cultures (LBMC) that support both early and late events in this lineage.' These cultures have been essential in defining regulatory cells and cytokines that affect the differentiation and proliferation of early B-lineage cells.
Although a number of cells appear to play a role in providing positive and negative signals that maintain steadystate production of B cells, data from BMC have established that the essential regulatory component for B-cell development in vitro appears to be a population of adherent fibroblastic stromal cells.435 These cells are presumed to be representative of the population of reticular cells present in intersinusoidal spaces of the marrow medullary cavity. 6 Several laboratories have recently cloned representative stromal cell lines from BMC,7-'4 and these cell lines have proven invaluable in studies of cytokines that regulate the proliferation and differentiation of B-lineage cells. Interleukin-7 (IL-7) was cloned from an SV40-transformed stromal cell line and was originally characterized as a proliferative factor for B-lineage cell^.'^-'^ In addition, more recent studies have shown a role for IL-7 in the pi-oliferation of thymocyte^,'^ mature peripheral T cell^,'^^'^ and lymphokineactivated killer (LAK) cells.2o Several groups recently identified the ligand for the protein product of c-kit, a membranebound receptor with tyrosine kinase and in one case the ligand for this receptor was cloned from a murine BM stromal cell line.u *' kit-ligand (KL) was recently shown to interact synergistically with IL-7 and to stimulate proliferation of B-lineage cells?6 In addition to these proliferative stimuli, stromal cells secrete an activity(s) that allows B220-precursors to mature to Ig expression. Stromal cell line S17 was previously shown to secrete cytokines that potentiated this differentiative step, and that process appeared to involve little or no proliferation."
During the course of studies aimed at characterizing this differentiative activity, S17 cells were observed to secrete an activity that synergized with IL-7 to potentiate the proliferation of LBMC nonadherent cells. Further analysis indicated that activity was due to secreted KL, and this observation raised the question of whether that factor was the S17-derived differentiation activity that allowed maturaments show that the stromal cell line S17 potentiates the proliferative effect of IL-7 on B-lineage cells and that this S17-derived potentiator can be replaced with recombinant kit-ligand (KL). Our results further show that pre-B-ell formation from B22O-, Ig-progenitor cells and expression of p heavy chain of immunoglobulin is uniquely depehdent on the presence of S I 7 stromal cells and cannot be reproduced with IL-7, KL, or costimulation with both IL-7 and KL. These data contribute to a rapidly evolving model of stromal cell regulation of B-cell production in the marrow and suggest unique roles for IL-7, KL, and as yet uncharacterized stromal cell-derived lymphokines in this process. tion of B220-precursors into pre-B cells. The data presented here demonstrate that this is not the case, and show that KL and IL-7 provide a proliferative stimulus to B-lineage cells only after they have differentiated to the B220' stage in response to a stimulus provided by stromal cells. These observations provide evidence for a model of primary B lymphopoiesis in which separable differentiative and proliferative signals are operative on cells at distinct times during their development.
MATERIALS AND METHODS
Male BALB/c mice, 3 to 6 weeks old, were obtained from Taconic Laboratories (Germantown, NY). All mice were housed in autoclaved microisolator cages (Lab Products, Maywood, NJ) in the West Virginia University Health Sciences Center Vivarium. Autoclaved food and acidified water (pH 2.8) were provided ad libitum.
Stromal cell lines S17 and S10 have been previously described in reports from this NIH-3T3 cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD). All three cell lines were grown to confluence in 75-cmZ flasks in a-minimal essential medium (a-MEM; GIBCO, Grand Island, NY) containing 5% fetal calf serum (FCS). Cells were passaged weekly by 0.25% trypsin (GIBCO) treatment of adherent cell layers. For proliferation assays, adher-
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ent cell lines cells were plated in 96-well disposable culture dishes (Corning Glassworks, Corning, NY) and used after a confluent cell layer was established. For short-term BM coculture experiments, cells were transferred to 24-well cell culture plates and used as confluent adherent layers of supporting cells that were separated from target cells by a cellulose 0.45 pm microporous membrane (Millicell-HA, Millipore, Bedford, MA).
In some experiments, conditioned medium (CM) was prepared by growing adherent cell lines to confluence in a-Modification of Eagle's Medium (Mediatech Cellgro, Washington, DC) containing 5% FCS (JR Scientific, Woodland, CA), 5 X mol/L 2-mercaptoethanol, 2 mmol/L L-glutamine, l@ U/mL penicillin G, and 100 pg/mL streptomycin. CM was collected at 96 hours of culture and stored as sterile unconcentrated CM in small aliquots at -85°C.
Hybridoma clone 14.8 was obtained from the ATCC (TIB 164) and grown as previously describedz7 in RPMI 1640 medium (GIBCO) containing 2% FCS and 1% Nutridoma-SP (Boehringer-Mannheim, Indianapolis, IN). 14.8 CM was concentrated 10-fold on Amicon XM-50 ultrafiltration membranes (Amicon, Danvers, MA) for use in these experiments. Affinity-purified goat-antirat Ig, fluorescein isothiocyanate (F1TC)-conjugated affinity-purified goat-antimouse A and goat-antimouse K light chains of Ig, and tetramethylrhodamine isothiocyanate (TR1TC)-conjugated affinity-purified goat-antimouse p-heavy chain of IgM antibodies were purchased from Southern Biotechnology Associates (Birmingham, AL). All antibodies were used at saturating concentrations in antibody binding studies.
Recombinant human IL-la (specific activity, 2.7 x lo8 U/mL) was obtained from Hoffmann LaRoche (Nutley, NJ). Recombinant murine IL-7 (lo7 U/mg) was obtained from Biosource International (Westlake Village, CA). The cDNA for secreted form of mouse KL (sKL) was cloned from NIH-3T3 cells by polymerase chain reaction (PCR). The sKLspecific primers used for PCR were 5'-CGT ACT GCA GCC TIT CCT TAT GAA GAA GAC ACA AAC TTG G-3' (sense) and TAC TGC TAC T-3' (antisense). The amplified product was subcloned into the PstI and &nI sites of the expression vector, ~C D L -S R C X~~~.~ COS-1 cells were transfected with psKL as previously described?' Briefly, COS-1 cells were grown to confluence in the same medium used to collect S17 CM and 5 x lo7 cells were transfected with 100 pg supercoiled psKL DNA by electroporation. At 24 hours, the culture medium was replaced with fresh serum-free medium. After an additional 48 hours of culture, CM was collected, sterile filtered, and frozen in small aliquots. COS-1 supernatants from cells transfected with psKL supported proliferation of the KL-responsive cell lines NFS-60 or MC9 with maximal activity at 10% of culture volume (data not presented).
The 1.5-kb Xho I IL-7 cDNA fragment was a generous gift from Dr S.I. Nishikawa.M The 1.5-kb Pst I cDNA fragment of GAPDH was used as previously described.) ' Mice were killed by cervical dislocation. Femurs and tibias were removed and the marrow plug flushed from bones with RPMI 1640 (GIBCO) containing 5% heat-inactivated FCS (HIFCS; Hyclone Laboratories, Logan, UT) using a syringe fitted with a 23-gauge needle. Bone spicules and debris were allowed to settle into an underlayer of HIFCS and cells were transferred to a second tube. Cell viability and cell counts were determined in a hemocytometer.
Adherent cells were depleted from BM cell suspensions or LBMC using G10 Sephadex. Sterile G10 columns were prepared exactly as previously described.'2 Briefly, sterile 10-mL syringe barrels were plugged with glass wool, autoclaved, and filled with 8 mL of sterile preswollen G10 Sephadex. Columns were washed with sterile phosphate-buffered saline (PBS) and
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equilibrated with 20 mL warm (37°C) RPMI 1640 containing 5% HIFCS. Two milliliters of medium containing no more than lo8 BM cells was applied to each column. Columns were incubated for 30 minutes at 37°C and nonadherent cells washed from columns with 30 to 35 mL of warm (37°C) medium.
Monoclonal antibody 14.8 binds to a determinant on the 220 Kd molecular weight form of CD45 (B220) cell surface molecule of lymphoid ~ells.2~ Depletion of cells with this cell surface antigen results in the removal of B-lineage cells that express either sIg (B cells) or cytoplasmic p-heavy chains of IgM (pre-B cells). In our studies, 14.8+ cells were depleted from cell suspensions on antibodycoated polystyrene Petri dishes (Falcon 1001; Becton Dickinson, Oxnard, CA) exactly as previously de~cribed.)"~ Petri dishes were first coated with affinity-purified goat antirat Ig (50 pg in 5 mL Tris buffer, pH 9.5) at room temperature for 70 minutes and then washed three times with PBS, pH 7.2. Plates were then incubated with 100 pg 14.8 antibody in 3 mL PBS at 4°C for 30 minutes. 14.8-coated plates were washed three times with ice-cold PBS, filled with 5 mL PBS containing 5% HIFCS, and held at 4°C until use. All plates were used the same day that they were prepared.
BM or LBMC cells were first depleted of adherent cells on G10 Sephadex. The remaining cells were then transferred to antibodycoated plates (2.5 x lo7 cells/plate) and incubated at 4°C for 70 minutes. In all experiments, cells were depleted on three sequential plates to stringently remove appropriate cells. Nonadherent cells from this series of depletions were collected as 14.8-(B cell and pre-B cell depleted) BM cells for use in experiments. Antibody depletions were checked by staining nonadherent cells with fluorescent labeled 14.8 antibody. Depletions were further monitored for efficiency of pre-B-cell removal by staining depleted cells for expression of Ig light chain and p-heavy chain expression as described below.
BM cells were depleted of adherent cells on G-10 Sephadex and pre-B cells by adherence to 14.8-coated Petri dishes as described above. Nonadherent and 14.8-cells were cultured at lo6 cells/mL in RPMI 1640 containing 5% FCS, 5 x mol/L 2-mercaptoethanol, essential and nonessential amino acids (GIBCO), 2 mmol/L L-glutamine, MEM vitamins (GIBCO), lo5 U/mL penicillin G, and 100 pg/mL streptomycin. In experiments that required an underlayer of stromal cells, BM cells were cultured in diffusion chamber culture inserts (Millipore-HA; Millipore, Bedford, MA) to prevent cell contact between nonadherent BM cells and stromal cells as previously described."
Lymphoid permissive BMC were set up exactly as originally described by Whitlock and Witte.' Briefly, suspended BM cells were cultured at an initial density of 1 x lo6 cells/mL in 10 mL RPMI 1640 containing 5% FCS in 100-cm2 polystyrene tissue culture grade petri dishes (Corning #1005) at 37°C and 6% CO, in ambient air. Cultures were initially fed an additional 5 mL of the same medium on day 3 of culture. For the remainder of culture, 10 mL of medium was removed once weekly and replaced with 10 mL of identical fresh cell culture medium. After 3 to 4 weeks, cultures were observed for the appearance of foci of lymphoid cells and nonadherent cells were collected for assays.
B and pre-B cells were identified by immunofluorescent staining of Ig light and heavy chains on fixed cytocentrifuged preparations as previously de~cribed.~' Briefly, lo5 cells were cytocentrifuged onto glass slides, air dried, and fixed in absolute ethanol containing 5% glacial acetic acid at -20°C for 15 minutes. Fixed preparations were rehydrated in 3 vol of PBS for 15 minutes each, and incubated with FITC-goat antimouse K light chain (50 pg/mL) and FITC-goat antimouse A light chain (50 pg/mL) containing 0.1% NaN, in a humidified chamber for 30 minutes at room temperature. Slides In all experiments that address the formation of pre-B cells in culture, the absolute number of pre-B cells generated is presented. This calculation of actual pre-B cells lost or gained in cultures prevents potential misinterpretation of data due to secondary frequency changes caused by net losses or gains in another cell population from the BM inoculum. In these experiments, cell viability for treated and control cultures did not vary more than 5%.
For proliferation assays, data presented are as mean counts per minute of at least three independent samples and include the standard error of the mean for each treatment group.
Proliferation assays.
Northern anaZysis.
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RESULTS
S17 stromal cells and IL-7 synergize in regulating the
proliferation of B-cell precursors. During the course of experiments aimed at characterizing cytokines produced by S17 stromal cells, the line was found to produce an activity that synergized with IL-7 in potentiating the proliferation of B-lineage cells. As shown in Fig 1, IL-7 alone supported proliferation of nonadherent lymphoid cells from LBMC, and this effect was saturable with maximal stimulation of proliferation achieved at 50 U/mL recombinant murine IL-7 (rmuIL-7). However, the magnitude of this proliferative response was significantly elevated when cultures were stimulated with IL-7 in the presence of S17 stromal cells. We also noted low but significant proliferation of LBMC nonadherent cells on S17 stroma alone, suggesting that S17 and IL-7 synergized in this assay. This synergistic proliferation response was not observed when S10 stromal cells or NIH-3T3 cells were used in place of S17 cells in this assay (data not presented).
In initial experiments, we noted considerable variation of proliferative stimulation indices for LBMC cells and identified several characteristics of nonadherent LBMC cells that affected the magnitude of the proliferative response. A direct relationship was observed between the age of LBMC used and proliferative response to IL-7 addition alone (data not shown). This elevation of IL-7-mediated proliferation in older cultures tended to obscure the synergistic response described above and, for that reason, all of the experiments presented used nonadherent cells from LBMC during the first 6 weeks after they began producing significant numbers of nonadherent cells. We also separated LBMC nonadherent cells into B220' and B220-cells in an attempt to determine whether both populations responded to S17 and IL-7 with a synergistic proliferative response. Both populations responded to this proliferative stimulus (data not presented); however, this result was not particularly revealing because both populations contained essentially identical numbers of Cp+, Ig-light chain-cells. This finding suggests that, although B220 and Ig expression are coordinately expressed in normal BM cells, this is apparently not true for lymphoid cells from LBMC.
Finally, a number of experiments were set up in reduced oxygen tension (5% 0, in N,) as previously des~ribed.'~~'~ No differences in IL-7 or S17 potentiated cell proliferation were found in companion cultures incubated under low or ambient oxygen tension. Ambient oxygen tension incubators were used for all of the cultures presented.
SI 7 stromal cells do not produce detectable IL-7 messenger
RNA ("A).
Although the synergistic costimulation of S17 stromal cells and IL-7 on lymphoid cell proliferation did not appear to be due to increases in IL-7 concentration (Fig l) , it remained possible that S17 cells expressed IL-7 in a manner that resulted in the observed increase in proliferation. To determine whether IL-7 mRNA transcripts could be detected in the S17 stromal cells used in this study,
adhcrcnt laycrs wcrc harvcstcd at 72 hours aftcr fccding, RNA was prcparcd as dcscribcd, and Northcrn blot analysis pcrformcd. IL-7 mcssagc was dctcctcd in RNA prcparcd from SI0 but not from SI7 stromal cclls (Fig  2) . To assurc that cquivalcnt amounts of RNA had bccn loadcd in cach lanc, blots wcrc strippcd and rchybridizcd with a 1.5-kb P.yt I cDNA fragmcnt of GAPDH."
Failurc to dctcct constitutivc IL-7 mRNA production by S17 stroma did not cxcludc thc possibility that its production could bc induccd. This is a rclcvant point in vicw of a report by Sudo et al that a stromal ccll linc that did not constitutively cxprcss IL-7 mcssagc could be induccd to do so aftcr 72 hours of coculturc with IL-I.'" As illustrated in Fig 2, thc addition of 1 to 100 U/mL rlL-la to confluent laycrs of SI7 for 72 hours bcforc RNA cxtraction did not rcsult in induction of IL-7 mRNA production (only data from I O U/mL IL-la trcatmcnt shown). IL-7 mcssagc rcmaincd undctcctablc in thcsc prcparations aftcr 30 rounds of PCR amplification (data not prcscntcd). On thc othcr hand, SI0 cclls did have dctcctablc constitutivc lcvcls of IL-7 mRNA and this stcady statc lcvcl of IL-7 gcnc transcription was not obviously clcvatcd by trcatmcnt with rIL-la (Fig 2) .
CM from SI7 celk can synergix with IL-7 and stimulate proliffration of R-cellprecitrsors. From thc abovc studics it was not clcar whcthcr thc IL-7 synergistic activity associated with SI7 cclls was cell bound or rclcascd into the medium. CM was collcctcd from conflucnt SI7 stromal cells as dcscribcd and used I X at SO% of culturc volume in prolifcration assays. As shown in Fig 3A, SI7 CM syncrgizcd with 50 U/mL rIL-7 in stimulating thc prolifcration of nonadhcrcnt cells from LBMC in the abscncc of an adhcrcnt ccll laycr. As bcforc, this synergistic cffcct was achicvcd with SO U/mL rIL-7 and furthcr incrcascs wcrc not obscrvcd with higher conccntrations of IL-7 (data not shown).
The contribution of S I 7 stromal cel1.s in the prol$eration of R-cellprecimors can be replaced b-y KL. One reccnt report suggcstcd that thc ligand for thc c-kit-cncodcd rcccptor may play a rolc in thc prolifcration of lymphoid CCIIS.'~ Because kit-ligand mRNA transcripts can bc easily dctccted in S17 cclls (unpublished rcsults), wc questioned whcthcr thc syncrgistic cffcct obscrvcd hcrc was duc to KL. As shown in Fig 3B, supcrnatants from COS-I cclls transfcctcd with a cDNA clonc cncoding KL syncrgizcd with IL-7 in this assay and complctcly rcproduccd thc effcct of SI7 cclls or supernatants. This cffcct was not observed with control COS-I supcrnatants (Fig 3B) .
Although thc abovc data indicate that IL-7 and KL together stimulate thc prolifcration of B-lincagc cells, it was also important to dcterminc whether these cytokincs potcntiatc diffcrcntiation of carly Ig-B-ccll progcnitors (pro-B cclls) and initiation of Cphcavy chain cxprcssion.
IL-7 is not produccd by the SI7 ccll linc (Fig 2) , and for that rcason is almost certainly not the factor responsible for the diffcrcntiative activity produccd by thosc stromal cclls. Howcvcr, thcsc data do not rulc out the possibility that IL-7 also has thc ability to potcntiatc maturation of immaturc B-ccll prccursors. Thc data in Fig 4 clcarly show that the addition of rmu IL-7 to B22O-deplctcd BM cells at concentrations of 25 to SO0 U/mL did not stimulate pre-B-ccll formation. Howcvcr, the addition of IL-7 to cultures that also containcd SI7 CM consistcntly rcsulted in greater numbcrs of prc-B cclls formcd as comparcd with cultures that containcd only SI7 CM (Fig 4) . This differcncc was incrcascd by cxtcnding culturcs to 48 hours (Fig 4) .
Because KL could rcplacc SI7 in the IL-7 costimulation assay for cell prolifcration described above, we qucstioncd whcthcr thc diffcrcntiation activity previously ascribcd to SI7 might reside with KL. As shown in Figs, neither COS-1 supernatants containing rsKL (Fig SA) nor the combination of rsKL and IL-7 (Fig 5B) Potentiated differentiation of Cv+, Ig light chain-cclls from B220-BM at any conccntration tcstcd. In addition, these data show that, whereas thc prcscncc of IL-7 in these cultures again rcsultcd in greater numbcrs of prc-B cclls in cultures containing SI7 CM, the addition of KL did not affect the number of pre-B cells found in culturcs that were potentiated with eithcr SI7 alonc or thosc containing both SI7 and IL-7.
R-lineage progenitor.Y that precede R220 and C p erpression are not expanded in the presence of IL-7 and KL. To dctcrminc whcther IL-7, KL, or thc combination of IL-7 and KL would stimulate expansion of cells that differentiate to Ck expression in the presencc of S17, B22O-depleted BM cclls werc cultured for up to 48 hours in the prcscncc of 100 U/mL rIL-7 or a combination of 100 U/mL IL-7 and 10%
Neither IL-7 nor KL siipport pre-R-ceN formation. 
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COS-sKL and then exposed to S17 CM in secondary culture for 24 hours. As before, pre-B cells were not generated in primary cultures containing either IL-7 or sKL + IL-7 (Table 1) . However, when S17 CM was added to these cultures at either 24 or 48 hours and cultures extended for and additional 24 hours (a total culture period of 48 and 72 hours, respectively) Cp+ cells were generated (Table 2) . Importantly, the number of pro-B cells (precursors of Cp+ pre-B cells) in cultures maintained for up to 72 hours in the presence of IL-7 or sKL and IL-7 was not different from that found from primary cultures enumerated at 24 hours (Table 1) . Taken together, these data strongly suggest that the addition of IL-7 and sKL to these in vitro cultures does not result in either expansion of B220-B-cell progenitors or differentiation of these cells to C p expression.
DISCUSSION
The aim of this study was to determine if IL-7 and an IL-7 synergistic activity secreted by the S17 stromal cell line, which appears to be KL, could potentiate the differentiation of B220-B-cell precursors into pre-B cells. The data clearly show that neither IL-7 nor KL alone or in combination mediated that event. Instead, the combination of IL-7 and KL apparently costimulate proliferation of pre-B cells after they have differentiated in the presence of as yet uncloned molecules produced by stromal cells. These results corroborate previous observations that KL and IL-7 act synergistically to stimulate proliferation of B-lineage cells and significantly extend these findings to show that additional cytokines are responsible for a separable developmental step in which the maturation of immature B-cell precursors to an IL-7/KL responsive state occurs.
Stromal cell line S17 has been previously shown to potentiate differentiation of early B-lymphoid cells from the marrow," but proliferative activity produced by this cell line has thus far been limited to effects on B220+ BM cells?' In this study we demonstrated that, although S17 stroma was not efficient in stimulating proliferation of isolated LBMC nonadherent cells, its presence potentiated the proliferative effect of IL-7. Two observations suggested that the synergistic stimulation of proliferation by IL-7 and S17 cells was not due to the contribution of additional IL-7 to the assay by S17 cells. First, the level of IL-7-induced proliferation in these assays was saturable, and did not increase significantly between 50 and 1,000 U/mL (Fig 1) .
We also could not demonstrate IL-7 mRNA in S17 cells by Northern analysis (Fig 2) or after 30 cycles of PCR amplification (unpublished observation). These data suggested the presence of a unique S17 stromal cell-derived cytokine that synergized with IL-7 in lymphoid cell proliferation.
One recent reportz6 suggested that BM adherent cells produce KL and that KL costimulated IL-7-mediated growth of B-lineage cells from normal BM. However, the adherent cells used in that study were an uncloned primary cell line and likely contained several cell types. We found that the cloned S17 stromal cell line produced several species of KL mRNA by Northern analysis (unpublished data) and tested whether this molecule could account for the S17-derived synergistic activity described herein. Recombinant KL reproduced the IL-7-potentiating effect of S17 supernatants in the absence of a stromal cell underlayer (Fig 3A) . While this observation does not rule out the possibility that S17 produces multiple cytokines that potentiate IL-7 effects, it strongly suggests that KL is a primary mediator of this effect.
Our previous studies showed that S17 stromal cells potentiated differentiation of pre-B cells (Cp+, Ig light chain-negative cells) from B220-progenitor cells resident in the marrow.'" Previous reports from this laboratory have shown that this pre-B-differentiation activity is released from BM stromal cells into the growth medium and that it resides with a relatively small ( < 10 Kd molecular weight) molecule in supernatants from the S17 cell line? The results presented here strongly suggest that this previously described activity of S17 cells does not appear to be due to KL, IL-7, or the combination of these two cytokines. Differentiation and proliferation of B-cell progenitors, then, appear to be regulated by different stromal cell-derived cytokines. S17 cells do not have detectable IL-7 mRNA or directly stimulate significant proliferation of B-lineage cells, but are efficient in stimulating differentiation of pre-B cells and potentiating IL-7-mediated expansion of differentiated cells.
For
org From
McNiece et aIz6 reported that the combined addition of IL-7 and KL stimulated differentiation of B220-depleted BM cells to detectable B220 expression. This conclusion is not supported by our studies and there are several possible explanations for this apparent difference. While our data are reported as absolute cell numbers from short-term cultures, McNiece et a1 used 14-day cultures and analyzed only the frequency of B220-expressing cells at the termination of culture. This difference in analysis is further complicated by the possibility that B220' cells remained in the cell population used for cultures. B220 depletion in our hands requires several rounds of depletion for efficient removal of detectable B220' and Cp+ cells from BM cell suspensions. B220 expression on these cells varies quantitatively and pre-B cells express lower density of this antigen than that found for B cells (unpublished observations). McNiece et report using a single depletion step and the resulting cell population used for culture may have included substantial numbers of cells that express B220 at low density. Certainly any remaining B220' pre-B cells would respond dramatically to the combination of IL-7 and KL used and predominate in cultures by 14 days. It should also be noted that the studies reported herein use C p expression as an independent marker of efficiency of B220 depletion to circumvent detection problems associated with possible B220 antigen modulation during the depletion procedure. Finally, because the two reports have used different endpoints (B220 and C p expression), it remains possible that IL-7 and KL stimulate either differentiation to B220 expression or proliferation of B220+, Ck-cells, but other stromal cell-derived cytokines are necessary for C p expression. Experiments are currently in progress to further resolve these differences.
These data contribute to our working knowledge of differentiation and expansion of this essential immune responsive cell population. In vivo kinetic data suggest that proliferation of Cp+ pre-B cells may not account for significant cell expansion in this lineage'* and could not account for the necessary expansion of cells that have related antibody specificity after Ig heavy chain rearrangement. Lee et all6 concluded that the majority of cells that proliferate in response to IL-7 are B220' and our results are clearly in agreement with that study. In addition, our studies have not detected significant expansion of pre-Bcell precursors (pro-B cells) in extended culture of B220-depleted BM in the presence of KL and IL-7 (Table 2) . Taken together, these data suggest that the B-lineage cell population responsible for clonotype expansion expresses B220 but not Cp. Cells with this phenotype have been previously described34 and are notably more frequent in embryonic liver than in postnatal mouse BM.39 Candidate target cells for IL-7-mediated proliferation may express B220 and have D-J Ig gene rearrangements but do not express detectable Cp-heavy hai in.^'^^^ Cells with this phenotype have been shown to proliferate for extended periods in the presence of IL-7 and BM stromal cells4' and may represent a discrete proliferating compartment in the B lineage that accounts for the necessary clonotype expansion in the marrow. Although these cells are capable of in vivo reconstitution of B cells in scid mice;' their relevance to expansion of normal B-lineage cells in the marrow, normal population size, and growth requirements of their normal counterparts require further investigation.
Regulation of B-cell development apparently depends on separable cytokines that affect cellular proliferation and differentiation. Differentiation of pro-B cells tb initiate Ig-heavy chain gene expression is regulated by secreted factors from S17 stromal cells that do not in and of themselves stimulate significant proliferation of these cells. Pre-B cells that express C p heavy chain and develop in the presence of stromal-derived differentiation cytokines are then receptive to IL-7-induced proliferation. The IL-7-dependent proliferative response of at least some of these pre-B cells can be upregulated by costimulation with KL; however, to date we have not detected differentiative potential for p r e -h e l l formation by any combination of these two cytokines. Costimulation with KL and IL-7, then, either results in recruitment of additional cells into cell cycle or expression of functional IL-7 receptor complexes on developing B-lineage cells that did not previously express them.
This working model of B-cell differentiation in the marrow contrasts dramatically with the regulation of proliferation and differentiation in myeloid lineages. Colonystimulating factors potentiate both proliferation and differentiation of target cells and purely differentiative signals have not been described. It will be important now to further characterize and clone differentiative cytokines produced by S17 cells and to determine whether they function as commitment or differentiation stimuli in the expression of differentiated cell phenotype in the lymphopoietic system. The role of KL in lymphopoiesis appears to be primarily a potentiating signal for the expansion of cells that have already undergone heavy chain gene rearrangement and expression of Cp. However, the proliferation of earlier cells in the lineage will likely involve related molecules.
